HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $214,884 | -51.2% | 6,198 | -47.4% | 0.59% | -45.8% |
| Q1 2023 | $440,034 | +73.9% | 11,794 | +84.6% | 1.09% | +567.1% |
| Q3 2021 | $253,000 | -13.4% | 6,388 | 0.0% | 0.16% | -20.4% |
| Q2 2021 | $292,000 | -82.4% | 6,388 | -84.2% | 0.21% | -84.1% |
| Q1 2021 | $1,658,000 | +13.6% | 40,356 | +17.8% | 1.30% | +24.6% |
| Q4 2020 | $1,459,000 | – | 34,250 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |